|
Volumn 23, Issue 1, 2013, Pages 179-182
|
Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors
|
Author keywords
Antiproliferative activity; Benzamide derivatives; Bioavailability; HDAC
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BENZAMIDE DERIVATIVE;
HISTONE DEACETYLASE INHIBITOR;
MOCETINOSTAT;
ANIMAL EXPERIMENT;
ANTINEOPLASTIC ACTIVITY;
ANTIPROLIFERATIVE ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG DESIGN;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
FEMALE;
IC 50;
IN VITRO STUDY;
MOUSE;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BENZAMIDES;
CELL LINE, TUMOR;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
HALF-LIFE;
HCT116 CELLS;
HISTONE DEACETYLASE INHIBITORS;
HISTONE DEACETYLASES;
HUMANS;
MCF-7 CELLS;
PYRIMIDINES;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
RATTUS;
|
EID: 84871024364
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.10.114 Document Type: Article |
Times cited : (9)
|
References (16)
|